Renal artery stenosis: epidemiology and treatment

Benjamin R Weber, Robert S DieterLoyola University Medical Center, Maywood, IL, USAAbstract: Renal artery stenosis (RAS) is a frequently encountered problem in clinical practice. The disease encompasses a broad spectrum of pathophysiologies and is associated with three major clinical syndromes: isc...

Full description

Bibliographic Details
Main Authors: Weber BR, Dieter RS
Format: Article
Language:English
Published: Dove Medical Press 2014-05-01
Series:International Journal of Nephrology and Renovascular Disease
Online Access:http://www.dovepress.com/renal-artery-stenosis-epidemiology-and-treatment-a16804
id doaj-95f5245cfcef47a5b8ceb0115addac40
record_format Article
spelling doaj-95f5245cfcef47a5b8ceb0115addac402020-11-24T20:46:20ZengDove Medical PressInternational Journal of Nephrology and Renovascular Disease1178-70582014-05-012014default16918116804Renal artery stenosis: epidemiology and treatmentWeber BRDieter RS Benjamin R Weber, Robert S DieterLoyola University Medical Center, Maywood, IL, USAAbstract: Renal artery stenosis (RAS) is a frequently encountered problem in clinical practice. The disease encompasses a broad spectrum of pathophysiologies and is associated with three major clinical syndromes: ischemic nephropathy, hypertension, and destabilizing cardiac syndromes. The two most common etiologies are fibromuscular dysplasia and atherosclerotic renal artery disease with atherosclerotic disease accounting for the vast majority of cases. Atherosclerotic renovascular disease has considerable overlap with atherosclerotic disease elsewhere and is associated with a poor prognosis. A wide range of diagnostic modalities and treatment approaches for RAS are available to clinicians, and with the advent of endovascular interventions, selecting the best course for a given patient has only grown more challenging. Several clinical trials have demonstrated some benefit with revascularization but not to the extent that many had hoped for or expected. Furthermore, much of the existing data is only marginally useful given significant flaws in study design and inherent bias. There remains a need for further identification of subgroups and appropriate indications in hopes of maximizing outcomes and avoiding unnecessary procedures in patients who would not benefit from treatment. In recent decades, the study of RAS has expanded and evolved rapidly. In this review, we will attempt to summarize the amassed body of literature with a focus on the epidemiology of RAS including prevalence, overlap with other atherosclerotic disease, and prognosis. We will also outline existing diagnostic and treatment approaches available to clinicians as well as summarize the findings of several major clinical trials. Finally, we will offer our perspective on future directions in the field.Keywords: atherosclerosis, hypertension, nephropathy, renovascular, stent, angioplasty, endovascularhttp://www.dovepress.com/renal-artery-stenosis-epidemiology-and-treatment-a16804
collection DOAJ
language English
format Article
sources DOAJ
author Weber BR
Dieter RS
spellingShingle Weber BR
Dieter RS
Renal artery stenosis: epidemiology and treatment
International Journal of Nephrology and Renovascular Disease
author_facet Weber BR
Dieter RS
author_sort Weber BR
title Renal artery stenosis: epidemiology and treatment
title_short Renal artery stenosis: epidemiology and treatment
title_full Renal artery stenosis: epidemiology and treatment
title_fullStr Renal artery stenosis: epidemiology and treatment
title_full_unstemmed Renal artery stenosis: epidemiology and treatment
title_sort renal artery stenosis: epidemiology and treatment
publisher Dove Medical Press
series International Journal of Nephrology and Renovascular Disease
issn 1178-7058
publishDate 2014-05-01
description Benjamin R Weber, Robert S DieterLoyola University Medical Center, Maywood, IL, USAAbstract: Renal artery stenosis (RAS) is a frequently encountered problem in clinical practice. The disease encompasses a broad spectrum of pathophysiologies and is associated with three major clinical syndromes: ischemic nephropathy, hypertension, and destabilizing cardiac syndromes. The two most common etiologies are fibromuscular dysplasia and atherosclerotic renal artery disease with atherosclerotic disease accounting for the vast majority of cases. Atherosclerotic renovascular disease has considerable overlap with atherosclerotic disease elsewhere and is associated with a poor prognosis. A wide range of diagnostic modalities and treatment approaches for RAS are available to clinicians, and with the advent of endovascular interventions, selecting the best course for a given patient has only grown more challenging. Several clinical trials have demonstrated some benefit with revascularization but not to the extent that many had hoped for or expected. Furthermore, much of the existing data is only marginally useful given significant flaws in study design and inherent bias. There remains a need for further identification of subgroups and appropriate indications in hopes of maximizing outcomes and avoiding unnecessary procedures in patients who would not benefit from treatment. In recent decades, the study of RAS has expanded and evolved rapidly. In this review, we will attempt to summarize the amassed body of literature with a focus on the epidemiology of RAS including prevalence, overlap with other atherosclerotic disease, and prognosis. We will also outline existing diagnostic and treatment approaches available to clinicians as well as summarize the findings of several major clinical trials. Finally, we will offer our perspective on future directions in the field.Keywords: atherosclerosis, hypertension, nephropathy, renovascular, stent, angioplasty, endovascular
url http://www.dovepress.com/renal-artery-stenosis-epidemiology-and-treatment-a16804
work_keys_str_mv AT weberbr renalarterystenosisepidemiologyandtreatment
AT dieterrs renalarterystenosisepidemiologyandtreatment
_version_ 1716812929748172800